Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept

Abstract

Post-approval RCTs on etanercept focus more on studies searching for new indications than on deepening knowledge about use. Ten years after the market entry of etanercept, one of the reasonable demands of clinical practice, for more comparative information, still remains unanswered.